Videos

Claire Snyder, MHS, PhD, associate professor of medicine and oncology with a joint appointment in health policy and management at Johns Hopkins School of Medicine, discusses questionnaires of patient-reported outcomes by patients and how they can lead to better treatment. 

Susan Krigel, PhD, psychologist at Midwest Cancer Alliance, the outreach arm of The University of Kansas Cancer Center, discusses factors that are closely associated with fear of recurrence among patients with cancer.

Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.

Gwendolyn Quinn, PhD, from Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida College of Medicine, discusses factors that can potentially impact fertility for patients with cancer.

Leslie Schover, PhD, clinical psychologist and professor of behavioral science at University of Texas at MD Anderson Cancer Center, discusses how nurses should approach patients suffering from sexual dysfunction after cancer.

Christian Nelson, PhD, of Memorial Sloan Kettering Cancer Center discusses care intervention that was developed specifically for older patients with cancer.

Nick Dionne-Odom, PhD, of University of Alabama at Birmingham School of Nursing discusses the impact that family caregivers have on patient survival.

Rebecca Sutphen, MD, from the University of South Florida, discusses the importance of connecting patients with clinical trials.

Anya Prince, JD, MPP, from The University of North Carolina at Chapel Hill, provides an overview of how insurance appeals can benefit a patient with cancer.

Frederic C. Kass, MD, discusses the importance of genetic counseling in oncology.

Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Norman (Carl) Swart, discusses the importance of palliative care for patients with cancer. Swart also comments on the importance of training nurses in this area.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Fred R. Hirsch, MD, PhD, professor of medicine, professor in pathology, University of Colorado, CEO, IASLC, discusses unmet needs in the treatment of lung cancer.

Kenneth Freundlich, neuropsychologist, Morris Psychological Group, Parsippany, NJ, discusses the need to support patients with hereditary cancers.

Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses how to talk to a patient about genetics and cancer risk.

Anees B. Chagpar, MD, MSc, MA, MPH, discusses the role of the nurse in a contralateral prophylactic mastectomy.

Shelagh Wright, PhD, a retired lecturer in psycho-oncology, Dublin City University, discusses challenges for nurses in pain management.

Mark Lazenby, PhD, APRN, FAPOS, associate professor, Yale School of Nursing, discusses tools to measure distress in a patient with cancer.

Jessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.

Suresh S. Ramalingam, MD, discusses important considerations for patients, caregivers, nurses and physicians when treatment with an immunotherapy begins.

Leslie R. Schover, PhD, Professor, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, explains how nurses can become more comfortable discussing sexual health with cancer patients. Sexual health side effects are common amongst cancer patients and survivors, but they are often not discussed, said Schover.

Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).

Gregory T. Armstrong, MD, MSCE, pediatric oncologist, St. Jude Children's Research Hospital, discusses a trial of 34,000 childhood cancer survivors.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Alice P. Chen, MD, Early Clinical Trials Development Program, National Cancer Institute, provides an overview of the NCI-MATCH trial.

K. Kelly Hancock, MSN, RN, NE-BC, Executive Chief Nursing Officer, Cleveland Clinic Health System, discusses coordination of care by nurse navigators.

David Carbone, MD, PhD, a survivor of lymphoma and director, James Thoracic Center, The Ohio State University Comprehensive Cancer - The James, discusses pain management in the context of being a patient and a physician.

Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.

Dana Bushman, a certified yoga instructor, provides advice for a patient with cancer beginning yoga.